Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
In recent years, there has been a proliferation of newer therapeutic agents, revolutionizing the treatment landscape for obesity
Data Extraction and Quality Assessment Two investigators (Hu and Song) independently extracted the following data by reviewing the full text of each study: first author, year of publication, Clinical Trial Registration Number (NCT ID), trial duration, patient characteristics, sample size, intervention (type of GLP-1 receptor agonist), comparators, and outcomes of interest
Cosmos Study May 16, 2024 Dual-Team Study Team A:Kersten Bartelt, RNBrendan Joyce Team B:Jeff Trinkl, MDJoe Deckert, PhD Key Findings Patients who lost less than 20 pounds on GLP-1 medications and were subsequently prescribed phentermine experienced greater weight loss while on phentermine in the year following GLP-1 treatment than patients who lost at least 20 pounds on the GLP-1 medication
therefore, ethical approval and informed consent were not required
Figure 2 2 Data of efficacy 2.1 Clinical trials: the SURPASS program The central clinical trial program designed to demonstrate the therapeutic effectiveness (in terms of GC and BW reduction), tolerability and safety of TZP in diabetic patients was the SURPASS program
In stock Description Additional information Reviews (0) Reviews Description 10ml Sterile Water Info: Sterile Water is a nonpyrogenic single-dose water used to dilute or dissolve chemicals prior to laboratory testing
US$ 23.77
US$ 25.57
US$ 25.74
US$ 29.78
